sever
acut
respiratori
syndrom
sar
infecti
diseas
caus
sar
coronaviru
case
death
report
much
progress
made
understand
sar
coronaviru
pathogenesi
infect
individu
remain
unclear
earli
report
show
old
age
diabet
mellitu
heart
diseas
risk
factor
advers
prognosi
sar
genet
host
factor
well
suppos
play
import
role
polymorph
sever
gene
test
associ
infect
three
studi
investig
role
angiotensin
convert
enzym
gene
diseas
pathogenesi
diseas
outcom
conflict
result
two
independ
studi
display
signific
role
mannosebind
lectin
mbl
genet
polymorph
sar
infect
candid
gene
mxa
gene
interferon
gamma
gene
rant
gene
gene
also
identifi
recent
studi
better
understand
gene
provid
new
insight
diseas
pathogenesi
knowledg
also
aid
identifi
biomark
evalu
efficaci
vaccin
intervent
cytokin
secret
activ
phagocyt
dendrit
cell
play
pivot
role
promot
immun
respons
cellmedi
immun
trigger
mani
biolog
function
stimul
prolifer
activ
nkcell
enhanc
nkcellmedi
cytolyt
activ
induc
product
tand
nkcell
trinchieri
product
induc
form
major
link
innat
adapt
immun
recent
studi
reveal
interferonmedi
immunopatholog
event
associ
atyp
innat
adapt
immun
respons
sar
patient
thu
reason
might
also
play
role
resist
sar
signal
direct
bind
molecul
receptor
il
shown
consist
least
two
distinct
subunit
associ
form
highaffin
complex
express
activ
nkcell
current
studi
hypothes
polymorph
gene
might
associ
sar
suscept
test
hypothesi
conduct
case
control
studi
investig
associ
genet
polymorph
sar
chines
individu
case
control
select
two
design
hospit
sar
beij
tianjin
sar
epidem
total
confirm
sar
patient
report
two
hospit
deriv
two
complet
unrel
super
spread
event
sse
patient
hospit
treatment
select
confirm
sar
case
studi
three
remain
patient
die
patient
unavail
studi
inconveni
revisit
diagnosi
made
accord
criteria
publish
chines
ministri
public
health
subsequ
confirm
antibodi
seroconvers
andor
detect
sarscov
rna
respiratori
secret
two
control
group
use
individu
close
contact
sar
patient
control
healthi
control
control
b
control
group
consist
subject
close
contact
confirm
sar
patient
infect
accord
criteria
defin
world
health
organ
among
individu
highrisk
health
care
worker
treat
sar
patient
prolong
durat
individu
share
meal
utensil
resid
ward
vehicl
etc
sar
patient
control
b
group
includ
healthi
unrel
chines
blood
donor
blood
drawn
juli
control
test
neg
igg
antibodi
sarscov
prior
includ
studi
subject
contribut
anticoagul
blood
written
inform
consent
obtain
also
use
standard
questionnair
collect
demograph
inform
includ
age
ethnic
region
origin
marit
statu
live
environ
educ
level
et
al
subject
confirm
genet
unrel
interview
comorbid
condit
might
effect
diseas
suscept
diabet
mellitu
heart
diseas
hypertens
asthma
tuberculosi
malign
trace
review
medic
record
self
report
studi
protocol
approv
ethic
committe
nation
center
aid
prevent
control
leucocyt
isol
within
h
blood
collect
use
percol
reagent
genom
dna
extract
use
cell
dna
extract
kit
biodev
inc
beij
china
follow
manufactur
instruct
type
sampl
previous
report
snp
caus
missens
mutat
code
sequenc
gene
name
ncbi
snp
id
rs
ncbi
snp
id
mr
ncbi
snp
id
rs
ct
hgbase
databas
id
genotyp
genom
dna
amplifi
use
primer
set
pcr
fragment
obtain
restrict
bbv
new
england
biolab
beverli
mass
us
type
hsp
promega
madison
wisc
usa
use
msp
promega
madison
wisc
usa
use
ct
use
restrict
bsr
new
england
biolab
pcr
carri
pcr
buffer
mgcl
trishcl
ph
kcl
triton
dntp
primer
unit
taq
polymeras
final
volum
follow
initi
denatur
min
sampl
subject
cycl
pcr
amplif
denatur
anneal
elong
follow
final
elong
step
min
reaction
product
pcr
enzym
restrict
analyz
agaros
gel
ct
polyacrylamid
gel
genotyp
sampl
perform
blind
manner
case
control
statu
known
ten
percent
sampl
chosen
randomli
polymorph
resequenc
order
valid
genotyp
method
genotyp
distribut
snp
test
equilibrium
chi
squar
test
three
group
genotyp
frequenc
sar
patient
control
subject
compar
odd
ratio
calcul
assign
refer
valu
homozyg
genotyp
frequent
control
subject
sar
patient
p
valu
calcul
multivari
logist
regress
analysi
age
sex
comorbid
presenc
infect
sourc
enter
covari
model
given
relev
potenti
confound
variabl
interpret
studi
result
data
analyz
use
spss
softwar
version
spss
inc
chicago
il
usa
correct
multipl
test
use
spectral
decomposit
spd
matric
pairwis
linkag
disequilibrium
ld
snp
adjust
multipl
test
take
account
ld
among
test
snp
method
show
pvalu
consid
statist
signific
correct
multipl
test
softwar
haploview
version
use
construct
haplotyp
genotyp
data
program
calcul
associ
statist
multilocu
haplotyp
casecontrol
data
use
expect
maximis
algorithm
estim
haplotyp
odd
ratio
across
multipl
categori
give
likelihood
ratio
test
homogen
tabl
show
baselin
characterist
sar
patient
two
control
group
mean
age
year
sar
case
year
control
group
year
control
b
group
sar
patient
control
group
control
b
group
male
sixtytwo
sar
patient
health
care
worker
thirtynin
patient
classifi
sever
group
base
admiss
intens
care
unit
death
due
diseas
age
male
femal
remain
patient
classifi
mild
group
age
male
femal
hardyweinberg
equilibrium
test
base
genotyp
frequenc
carri
separ
three
group
individu
control
b
group
genotyp
distribut
snp
ct
hardyweinberg
equilibrium
patient
group
genotyp
distribut
ct
polymorph
deviat
slightli
hardyweinberg
equilibrium
data
shown
genotyp
result
miss
patient
dna
sampl
enough
loci
detect
poor
rflp
result
led
exclus
analysi
allel
frequenc
four
loci
compar
tabl
ct
allel
shown
overrepres
group
patient
compar
control
group
pvalu
control
b
group
pvalu
howev
nyholt
correct
appli
screen
step
p
valu
turn
signific
allel
frequenc
three
snp
gc
significantli
differ
sar
patient
two
control
group
p
valu
great
genotyp
frequenc
four
loci
shown
tabl
signific
differ
genotyp
frequenc
sar
patient
control
found
ct
snp
p
ct
ct
tt
genotyp
significantli
repres
patient
respect
control
group
respect
compar
cc
genotyp
ct
tt
genotyp
found
associ
increas
suscept
sar
infect
or
ci
respect
genotyp
analysi
ct
sar
patient
control
group
yield
differ
result
patient
control
b
group
control
b
group
compar
differ
genotyp
distribut
detect
genotyp
frequenc
ag
gc
snp
significantli
differ
sar
patient
two
control
group
sar
patient
divid
two
subgroup
accord
sever
diseas
advanc
subgroup
ie
patient
moder
advanc
lung
diseas
mild
subgroup
multipl
regress
model
reestablish
snp
age
sex
sourc
infect
hospit
covari
associ
sever
sar
infect
estim
compar
genotyp
frequenc
allel
frequenc
snp
two
group
sar
patient
final
model
build
disclos
promin
associ
advanc
diseas
carri
ct
ct
tt
genotyp
p
howev
found
signific
nyholt
correct
appli
analysi
signific
differ
genotyp
allel
distribut
ag
gc
snp
mild
diseas
advanc
diseas
data
shown
pairwis
linkag
disequilibrium
ld
analysi
four
snp
show
strong
ld
among
ag
snp
modest
ld
valu
ct
one
three
snp
thu
reveal
two
common
haplotyp
atgc
gcct
investig
particular
haplotyp
constitut
snp
associ
diseas
haplotyp
frequenc
estim
associ
analysi
perform
use
multipl
logist
regress
age
sex
infect
sourc
covari
shown
tabl
frequenc
gcct
haplotyp
sar
patient
significantli
increas
compar
control
group
compar
control
b
group
proport
haplotyp
two
group
differ
sar
patient
vs
control
previous
report
associ
infecti
diseas
tuberculosi
hepat
b
viru
infect
parvoviru
infect
reveal
potenti
role
function
host
defens
microbi
infect
genotyp
snp
ct
alleg
caus
missens
mutat
gene
sar
patient
close
contact
healthi
control
four
snp
one
novel
confirm
caus
missens
variant
extracellular
code
sequenc
four
snp
lie
within
span
genom
dna
chromosom
suggest
one
four
missens
variant
could
affect
qualiti
quantiti
gene
product
caus
mild
function
impair
receptor
respons
result
show
individu
ct
ct
tt
genotyp
increas
risk
suscept
sar
infect
sever
patient
consid
signific
disappear
comparison
mild
patient
also
estim
frequenc
haplotyp
compos
polymorph
allel
identifi
risk
haplotyp
gcct
might
confer
genet
suscept
sar
infect
agreement
find
ct
allel
among
risk
haplotyp
gcct
wherea
altern
c
allel
among
protect
haplotyp
gccc
find
support
associ
polymorph
sar
infect
necessari
diseas
outcom
chines
popul
interest
note
associ
exist
close
contact
use
control
group
healthi
blood
donor
use
control
associ
could
detect
reason
genet
differ
two
control
group
might
partli
account
distinct
observ
regard
sar
suscept
ie
close
contact
might
immunogenet
resist
sar
infect
healthi
control
case
close
contact
might
serv
suitabl
control
healthi
individu
never
expos
sarscov
well
intrigu
pattern
polymorph
ct
sar
patient
deviat
slightli
hardyweinberg
equilibrium
note
previou
studi
detect
hw
disequilibrium
snp
loci
case
sampl
could
indic
diseasesuscept
gene
within
region
also
possibl
indic
like
pseudosnp
present
dna
contamin
genotyp
error
howev
latter
possibl
unlik
sinc
duplic
genotyp
assay
sampl
ambigu
result
sequenc
also
argu
observ
perfect
adher
hardyweinberg
disequilibrium
control
group
chanc
subgroup
minor
sinc
subject
chines
han
popul
without
consanguin
relationship
taken
togeth
suggest
deviat
correl
genet
variant
diseas
instead
fals
associ
sar
pathogenesi
less
well
understood
yet
vital
issu
diseas
manag
suggest
genet
variat
host
andor
viru
may
account
individu
differ
sever
diseas
studi
address
host
gene
might
play
role
diseas
develop
howev
avail
studi
fail
take
viral
factor
consider
studi
thu
exclud
possibl
fals
associ
caus
differenti
viral
adapt
human
sar
patient
current
studi
mostli
health
care
worker
two
sarsdesign
hospit
epidemiolog
investig
clearli
defin
detail
transmiss
among
patient
show
group
came
one
super
spread
chain
aris
one
infect
sourc
multipl
logist
analysi
use
infect
sourc
one
covari
could
technic
exclud
potenti
confound
effect
might
caus
viral
factor
advanc
age
presenc
comorbid
two
factor
might
influenc
diseas
suscept
exclud
potenti
confound
multipl
variant
analysi
mention
subject
genotyp
due
inadequaci
dna
sampl
especi
snp
differ
percentag
genotyp
miss
sar
control
control
b
group
respect
one
reason
argu
anoth
snp
account
increas
fraction
subject
without
defin
genotyp
sar
patient
group
also
argu
signific
snp
actual
function
variant
protein
instead
presum
linkag
disequilibrium
potenti
function
variant
loci
gene
present
code
nonsynonym
snp
list
entrez
databas
dbsnp
total
known
human
snp
howev
genotyp
snp
small
group
current
popul
show
maf
minor
allel
frequenc
less
unpublish
data
thu
propos
lack
complet
analysi
snp
gene
pose
sever
damag
studi
still
could
formal
exclud
possibl
addit
causal
variat
elsewher
gene
sequenc
exon
promot
region
gene
sar
patient
cohort
could
help
identifi
snp
could
alter
gene
express
level
would
also
warrant
examin
whether
associ
observ
ethnic
group
hand
rel
small
sampl
size
inevit
result
limit
power
detect
signific
associ
diseas
outcom
neg
result
snp
diseas
outcom
reveal
studi
necessarili
exclud
associ
sar
one
previou
studi
mark
elev
plasma
sar
patient
observ
least
week
diseas
onset
sinc
induc
product
cytokin
suppress
pathway
observ
earli
elev
could
caus
sarscovinduc
activ
cell
nk
cell
releas
chemokin
result
pulmonari
inflamm
one
could
hypothes
decreas
activ
might
predispos
infect
protect
sever
diseas
manifest
howev
data
present
appear
suggest
activ
requir
protect
sever
diseas
although
associ
genet
polymorph
sever
diseas
longer
signific
multipl
test
correct
appli
analysi
therefor
actual
role
protect
suscept
sever
diseas
still
need
evid
anim
experi
summari
data
support
associ
polymorph
sar
genet
variat
might
predispos
individu
sar
infect
diminish
receptor
respons
lead
partial
dysfunct
immun
genet
biolog
studi
genet
variant
could
also
render
valuabl
insight
sar
suscept
pathogenesi
